Home Healthcare Pharmaceuticals Brain Tumor Treatment Market

Brain Tumor Treatment Market Size, Share & Trends Analysis Report By Tumor Type (Primary Brain Tumor, Metastatic Brain Tumor), By Treatment Type (Chemotherapy, Immunotherapy, Gene & Cell Therapy, Targeted Therapy, Tumor-Treating Field & Electrotherapy, Radiotherapy Adjuncts) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: October 12, 2026 | Author: Debashree Bora | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Brain Tumor Treatment Market, By Tumor Type  2025-2034 (USD MILLION/ Units)
    1. Primary Brain Tumor 
      1. Glioblastoma Multiforme
      2. Astrocytoma
      3. Oligodendroglioma
      4. Ependymoma
      5. Meningioma
      6. Medulloblastoma
      7. Pituitary Tumors
    2. Metastatic Brain Tumor 
  2. Brain Tumor Treatment Market, By Treatment Type  2025-2034 (USD MILLION/ Units)
    1. Chemotherapy 
    2. Immunotherapy 
    3. Gene & Cell Therapy 
    4. Targeted Therapy 
    5. Tumor-Treating Field & Electrotherapy 
    6. Radiotherapy Adjuncts 
  3. Regional Brain Tumor Treatment Market
    1. North America
      1. North America Brain Tumor Treatment Market By Tumor Type  2025-2034 (USD MILLION/ Units)
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
      2. North America Brain Tumor Treatment Market By Treatment Type  2025-2034 (USD MILLION/ Units)
        1. Chemotherapy 
        2. Immunotherapy 
        3. Gene & Cell Therapy 
        4. Targeted Therapy 
        5. Tumor-Treating Field & Electrotherapy 
        6. Radiotherapy Adjuncts 
      3. U.S.
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      4. Canada
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
    2. Europe
      1. Europe Brain Tumor Treatment Market By Tumor Type  2025-2034 (USD MILLION/ Units)
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
      2. Europe Brain Tumor Treatment Market By Treatment Type  2025-2034 (USD MILLION/ Units)
        1. Chemotherapy 
        2. Immunotherapy 
        3. Gene & Cell Therapy 
        4. Targeted Therapy 
        5. Tumor-Treating Field & Electrotherapy 
        6. Radiotherapy Adjuncts 
      3. U.K.
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      4. Germany
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      5. France
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      6. Spain
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      7. Italy
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      8. Russia
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      9. Nordic
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      10. Benelux
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      11. Rest of Europe
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
    3. APAC
      1. APAC Brain Tumor Treatment Market By Tumor Type  2025-2034 (USD MILLION/ Units)
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
      2. APAC Brain Tumor Treatment Market By Treatment Type  2025-2034 (USD MILLION/ Units)
        1. Chemotherapy 
        2. Immunotherapy 
        3. Gene & Cell Therapy 
        4. Targeted Therapy 
        5. Tumor-Treating Field & Electrotherapy 
        6. Radiotherapy Adjuncts 
      3. China
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      4. Korea
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      5. Japan
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      6. India
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      7. Australia
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      8. Taiwan
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      9. South East Asia
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      10. Rest of Asia-Pacific
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
    4. Middle East and Africa
      1. Middle East and Africa Brain Tumor Treatment Market By Tumor Type  2025-2034 (USD MILLION/ Units)
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
      2. Middle East and Africa Brain Tumor Treatment Market By Treatment Type  2025-2034 (USD MILLION/ Units)
        1. Chemotherapy 
        2. Immunotherapy 
        3. Gene & Cell Therapy 
        4. Targeted Therapy 
        5. Tumor-Treating Field & Electrotherapy 
        6. Radiotherapy Adjuncts 
      3. UAE
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      4. Turkey
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      5. Saudi Arabia
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      6. South Africa
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      7. Egypt
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      8. Nigeria
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      9. Rest of MEA
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
    5. LATAM
      1. LATAM Brain Tumor Treatment Market By Tumor Type  2025-2034 (USD MILLION/ Units)
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
      2. LATAM Brain Tumor Treatment Market By Treatment Type  2025-2034 (USD MILLION/ Units)
        1. Chemotherapy 
        2. Immunotherapy 
        3. Gene & Cell Therapy 
        4. Targeted Therapy 
        5. Tumor-Treating Field & Electrotherapy 
        6. Radiotherapy Adjuncts 
      3. Brazil
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      4. Mexico
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      5. Argentina
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      6. Chile
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      7. Colombia
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
      8. Rest of LATAM
        1. Primary Brain Tumor 
          1. Glioblastoma Multiforme
          2. Astrocytoma
          3. Oligodendroglioma
          4. Ependymoma
          5. Meningioma
          6. Medulloblastoma
          7. Pituitary Tumors
        2. Metastatic Brain Tumor 
        3. Chemotherapy 
        4. Immunotherapy 
        5. Gene & Cell Therapy 
        6. Targeted Therapy 
        7. Tumor-Treating Field & Electrotherapy 
        8. Radiotherapy Adjuncts 
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.